Charles Schwab Investment Management Inc. Decreases Stock Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Charles Schwab Investment Management Inc. lessened its holdings in Nu Skin Enterprises, Inc. (NYSE:NUSFree Report) by 21.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 715,577 shares of the company’s stock after selling 192,487 shares during the period. Charles Schwab Investment Management Inc. owned about 1.44% of Nu Skin Enterprises worth $4,930,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Jane Street Group LLC raised its position in Nu Skin Enterprises by 358.4% in the third quarter. Jane Street Group LLC now owns 924,993 shares of the company’s stock valued at $6,817,000 after purchasing an additional 723,220 shares during the period. Weiss Asset Management LP acquired a new stake in shares of Nu Skin Enterprises in the third quarter valued at about $2,727,000. Walleye Capital LLC raised its holdings in shares of Nu Skin Enterprises by 335.3% during the 3rd quarter. Walleye Capital LLC now owns 289,236 shares of the company’s stock valued at $2,132,000 after buying an additional 222,793 shares during the period. JPMorgan Chase & Co. lifted its position in Nu Skin Enterprises by 175.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company’s stock worth $1,710,000 after acquiring an additional 147,784 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC boosted its holdings in Nu Skin Enterprises by 27.7% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 603,555 shares of the company’s stock worth $4,448,000 after acquiring an additional 130,980 shares during the period. Institutional investors and hedge funds own 82.84% of the company’s stock.

Analyst Ratings Changes

NUS has been the topic of a number of analyst reports. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Tuesday, February 25th. DA Davidson dropped their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research note on Friday, December 20th.

View Our Latest Research Report on Nu Skin Enterprises

Nu Skin Enterprises Price Performance

NUS stock opened at $6.83 on Wednesday. The stock’s 50 day moving average is $7.35 and its two-hundred day moving average is $7.08. Nu Skin Enterprises, Inc. has a 52-week low of $5.95 and a 52-week high of $14.04. The company has a market capitalization of $339.61 million, a PE ratio of -2.32 and a beta of 1.06. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The business had revenue of $445.55 million during the quarter, compared to analyst estimates of $441.10 million. Analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were paid a $0.06 dividend. The ex-dividend date was Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a yield of 3.51%. Nu Skin Enterprises’s dividend payout ratio (DPR) is -8.14%.

Nu Skin Enterprises Company Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Stories

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUSFree Report).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.